80208-2
Leishmania infantum+donovani IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
Active
Term Description
This assay detects antibodies against Leishmania donovani IgG for L. infantum screening based on the known cross reactivity between L. donovani and L. infantum. If the Leishmania IIFT is positive, a monospecific test (example Westernblot) can be performed to differentiate the pathogenic agents and confirm the diagnosis. Immunoglobulin specific slides distinguish between IgG, IgM and IgA. No reaction at a 1:320 titer indicates no IgG class antibodies against Leishmania donovani are detected, but infection cannot be excluded. A reaction of a titer at 1:320 is positive indicating a former or acute infection. This term was created for, but not limited in use to, the submitter's Anti-Leishmania donovani indirect immunofluorescence test kit.
Part Description
LP201795-4 Leishmania infantum+donovani
Leishmaniasis is a vector-borne disease transmitted by sandflies and caused by intracellular protozoa of the genus Leishmania. Human infection is caused by about 21 of 30 species that infect mammals, including the L. donovani complex with 3 species (L. donovani, L. infantum, and L. chagasi); the L. mexicana complex with 3 main species (L. mexicana, L. amazonensis, and L. venezuelensis); L. tropica; L. major; L. aethiopica; and the subgenus Viannia with 4 main species (L. (V.) braziliensis, L. (V.) guyanensis, L. (V.) panamensis, and L. (V.) peruviana). The different species are morphologically indistinguishable, but they can be distinguished by isoenzyme analysis, molecular methods, or monoclonal antibodies. Leishmaniasis is found in about 88 countries, most in the tropics and subtropics. More than 90 percent of the world's cases of visceral leishmaniasis are in India, Bangladesh, Nepal, Sudan, and Brazil. Leishmaniasis is also found in Mexico, Central America, and South America, from northern Argentina to Texas (not in Uruguay, Chile, or Canada), southern Europe, Asia (not Southeast Asia), the Middle East, and Africa. Human Leishmaniasis comprises multiple clinical syndromes; visceral, cutaneous, and mucosal forms. Infections can result in two main forms of disease, cutaneous leishmaniasis and visceral leishmaniasis (kala-azar). Different species can be associated with diverse clinical manifestations and sequelae. Species identification can facilitate clinical management. Cutaneous leishmaniasis is characterized by cutaneous lesions. Visceral leishmaniasis presents with fever, weight loss, and an enlarged spleen and liver. Visceral leishmaniasis is becoming an important opportunistic infection in regions where it coexists with HIV.
Source: Centers for Disease Control and Prevention,
CDC: Leishmaniasis
LOINC Names Get Info
- Fully-Specified Name
- Leishmania infantum+donovani Ab.IgG:
Titr: Pt: Ser/Plas: SemiQn: IF - Long Common Name
- Leishmania infantum+donovani IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
- Short Name
- L infantum+donovani IgG Titr SerPl IF
- Display Name
- L. infantum+donovani IgG IF [Titer]
- Consumer Name Alpha Get Info
- Leishmania infantum+donovani IgG antibody, Blood
Part Model Get Info
- Component
- Leishmania infantum+donovani Ab.IgG
LP201793-9
- Analyte
- Leishmania infantum+donovani Ab.IgG
LP201793-9
- Component Numerator
- Leishmania infantum+donovani Ab.IgG
LP201793-9
- Component Numerator Core
- Leishmania infantum+donovani
LP201795-4
- Component Numerator Core Suffix
- Ab.IgG
LP32401-9
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Titr
LP6881-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- SemiQn
LP436123-6
- Method
- IF
LP6323-2
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.54
- Last Updated
- Version 2.75 (MAJ)
- Order vs. Observation
- Both
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Leishmania infantum+donovani IgG: |
| el-GR | Greek (Greece) | Πρωτόζωο Leishmania infantum+donovani (Λεϊσμάνια) Αντισώματα IgG: Synonyms: MICRO Pt Titr Ανοσοσφαιρίνη G Ανοσοφθορισμός Αντίσωμα Αντισώματα IgG Ημιποσοτική Ορός Ορός/Πλάσμα Πλάσμα Πρωτόζωο Leishmania infantum+donovani (Λεϊσμάνια) |
| es-ES | Spanish (Spain) | Leishmania infantum+donovani IgG: Synonyms: Semicuantitativo |
| es-MX | Spanish (Mexico) | Leishmania infantum + donovani Ab.IgG: |
| fr-FR | French (France) | Leishmania infantum+Leishmania donovani Ac IgG: |
| it-IT | Italian (Italy) | Leishmania infantum+donovani Ab.IgG: Synonyms: anticorpi IgG anticorpo Immunofluorescenza (IF) Microbiologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma Titolo |
| nl-NL | Dutch (Netherlands) | Leishmania infantum + donovani As.IgG: Synonyms: antistof; |
| pl-PL | Polish (Poland) | Leishmania infantum+donovani Ab.IgG: Synonyms: IgG Leishmania infantum Leishmania infantum+donovani Przeciwciała do Leishmania infantum i donovani przeciwciała IgG Przeciwciała IgG do Leishmania infantum i donovani |
| zh-CN | Chinese (China) | 婴儿利什曼原虫+杜氏利什曼原虫 抗体.IgG: Synonyms: Ab.IgG; |
Example Units
| Unit | Source |
|---|---|
| {titer} | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://